SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Sheryl Sandberg's harrowing documentary exposes Hamas sex crimes

Mobileye first quarter revenue falls by almost 50% as clients cut back on spending to clear excess stock

Melio names Boaz BenDavid as its first Chief Financial Officer

Check Point registers higher than expected Q1 profit helped by growth of AI-powered security platform

Buzz

Most popular

Daily

Weekly

1

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

2

Nvidia announces $700 million acquisition of Run:ai

3

Nvidia continues Israel shopping spree with acquisition of Deci

4

Sheryl Sandberg's harrowing documentary exposes Hamas sex crimes

5

Bezos Earth rules out $30 million investment in Israeli alternative protein center due to war

Teva Pharmaceutical Industries

6 stories about Teva Pharmaceutical Industries

מנכ"ל טבע החדש קור שולץ 2

Troubled Drugmaker Teva to Axe over 4,000 Jobs

23.11.17|Golan Hazani

Less than a month after stepping in as CEO, Kåre Schultz starts tightening the belt. The company is expected to oust Chief Scientific Officer Michael Hayden

מנכ"ל טבע החדש קור שולץ 2

New Teva CEO Kåre Schultz to Relocate to Israel

17.10.17|Golan Hazani

Mr. Schultz, who led Copenhagen-based H. Lundbeck A/S since 2015, will come to Israel and assume his new position by the end of the month

חברת ה תרופות טבע Teva

Teva’s Stock Drops After Approval of Copaxone Competitors

08.10.17|Lilach Baumer

A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug

מנכ"ל טבע החדש קור שולץ

The Ten Challenges Facing Teva's New CEO

12.09.17|Sophie Shulman

Kåre Schultz is the right man for the job, but he's facing multiple problems, from a changing market to a problematic board

Teva Sells IUD Business for $1.1 Billion

12.09.17|Lilach Baumer

Going forward, the company will focus on central nervous system and respiratory treatments, shedding its Women's Health and Oncology and Pain businesses

קור שולץ מנכ"ל טבע החדש

Teva Appoints Lundbeck's Schultz as CEO

11.09.17|Dror Reich and Micky Grunfeld

The company’s announcement brings an end to a seven month search for a CEO to lead the troubled generic drugmaker. Updated

Previous Articles